ARCHIVES

“Alternative” Is Misleading Term, President’s Cancer Panel Writes To Healy

This article is from The Cancer Letter archive.

Vol. 19 No. 06 | February 5, 1993

Download PDF Visit The Full Archive

Related Articles

In Brief: CTEP Files IND For Antineoplaston, Mayo, MSK, Plan Trials; Researcher Escapes Bosnia

August 6, 1993

More Bad News For Estrogen: Increased Ovarian Cancer Risk

July 19, 2002

In Brief: George Vande Woude Of NCI Named PI for Litton Bionetics Basic Research Contract At Frederick

September 23, 1983

In Brief: UC Irvine Wins Grant For Trial Of One-Visit Cervical Cancer Screening, Treatment

November 6, 1998

In Brief: Search Narrows ACS Head; Selections For Breast Cancer Commission Still At HHS

March 27, 1992

Risk-Benefit Analysis Advised Prior To Hormone Therapy

August 27, 2010